Research programme: Fms like tyrosine kinase 3 inhibitors - Proteros biostructuresAlternative Names: Covalent Flt3-Cys828 inhibitors - Proteros biostructures
Latest Information Update: 03 Jun 2016
At a glance
- Originator Proteros Biostructures
- Class Antineoplastics; Small molecules
- Mechanism of Action Fms-like tyrosine kinase 3 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Acute myeloid leukaemia